These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39156380)

  • 1. Study of Use of Dabigatran in Cerebral Venous Sinus Thrombosis.
    Nirhale S; Rohatgi S; Rao P; Naphade P; Hatekar KS
    Cureus; 2024 Jul; 16(7):e64744. PubMed ID: 39156380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis.
    Ferro JM; Dentali F; Coutinho JM; Kobayashi A; Caria J; Desch M; Fraessdorf M; Huisman H; Diener HC
    Int J Stroke; 2018 Oct; 13(7):766-770. PubMed ID: 29775170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis.
    Ferro JM; Bendszus M; Jansen O; Coutinho JM; Dentali F; Kobayashi A; Aguiar de Sousa D; Neto LL; Miede C; Caria J; Huisman H; Diener HC;
    Int J Stroke; 2022 Feb; 17(2):189-197. PubMed ID: 33724104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulants in the treatment of cerebral venous sinus thrombosis: a single institution's experience.
    Rusin G; Wypasek E; Papuga-Szela E; Żuk J; Undas A
    Neurol Neurochir Pol; 2019; 53(5):384-387. PubMed ID: 31454061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dabigatran etexilate versus warfarin in cerebral venous thrombosis in Chinese patients (CHOICE-CVT): An open-label, randomized controlled trial.
    Ma H; Gu Y; Bian T; Song H; Liu Z; Ji X; Duan J
    Int J Stroke; 2024 Jul; 19(6):635-644. PubMed ID: 38353219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of magnetic resonance imaging and magnetic resonance venography changes in cerebral venous sinus thrombosis.
    Zafar A; Ali Z
    J Ayub Med Coll Abbottabad; 2012; 24(1):63-7. PubMed ID: 23855098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Observational Study to Evaluate the Effectiveness of Rivaroxaban in the Management of Cerebral Venous Sinus Thrombosis.
    Fatima M; Asghar MS; Abbas S; Iltaf S; Ali A
    Cureus; 2021 Mar; 13(3):e13663. PubMed ID: 33824814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.
    Ferro JM; Coutinho JM; Dentali F; Kobayashi A; Alasheev A; Canhão P; Karpov D; Nagel S; Posthuma L; Roriz JM; Caria J; Frässdorf M; Huisman H; Reilly P; Diener HC;
    JAMA Neurol; 2019 Dec; 76(12):1457-1465. PubMed ID: 31479105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dural Arteriovenous Fistulae After Cerebral Venous Thrombosis.
    Ferro JM; Coutinho JM; Jansen O; Bendszus M; Dentali F; Kobayashi A; van der Veen B; Miede C; Caria J; Huisman H; Diener HC;
    Stroke; 2020 Nov; 51(11):3344-3347. PubMed ID: 32972315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trial Based Rationale for the Successful Use of DOAC in the Treatment of Cerebral Venous Sinus Thrombosis (CVST): A Case Report.
    Bando T; Ueno Y; Shimo D; Kuroyama T; Mikami K; Hori S; Hirai O
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105261. PubMed ID: 33066921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dabigatran etexilate: a review of its use in the treatment of acute venous thromboembolism and prevention of venous thromboembolism recurrence.
    Greig SL; McKeage K
    Drugs; 2014 Oct; 74(15):1785-800. PubMed ID: 25270377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile and risk factors of cerebral venous sinus thrombosis (CVST) in Sudan: A multicenter cross-sectional study.
    Ibrahim EAA; Hassan Mohamed RE; Hussien Mohamed Ahmed KA; Haroun MS; Abdalla YA; Abdalla Omer ME; Mahmmoud Fadelallah Eljack M
    Ann Med Surg (Lond); 2022 Dec; 84():104891. PubMed ID: 36536723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of dabigatran etexilate for the treatment of venous thrombosis.
    Feuring M; van Ryn J
    Expert Opin Drug Discov; 2016 Jul; 11(7):717-31. PubMed ID: 27159158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Outcomes of Pediatric Cerebral Venous Sinus Thrombosis: An Analysis of 30 Cases in China.
    Wang XH; Zhang LM; Chai YM; Wang J; Yu LF; Zhou SZ
    Front Pediatr; 2019; 7():364. PubMed ID: 31552208
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of clinical, radiological and etiological profile of cerebral venous sinus thrombosis at a tertiary care center.
    Anadure RK; Wilson V; Sahu S; Singhal A; Kota S
    Med J Armed Forces India; 2018 Oct; 74(4):326-332. PubMed ID: 30449917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Vitamin K Antagonist Oral Anticoagulants for the Treatment of Cerebral Venous Sinus Thrombosis: a Retrospective, Matched Cohort Analysis.
    Giles JA; Balasetti VKS; Zazulia AR
    Neurocrit Care; 2021 Dec; 35(3):783-788. PubMed ID: 34046861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 44-Year-Old Male With Cerebral Venous Sinus Thrombosis.
    Shabbir T; Hunsucker R; Martin D; Shabbir Z; Abou-El-Hassan H; Salahuddin T
    Cureus; 2023 Mar; 15(3):e36974. PubMed ID: 37139286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Observational Study Comparing the Safety and Efficacy of Conventional Anticoagulation Versus New Oral Anticoagulants in the Management of Cerebral Venous Sinus Thrombosis.
    Shahid R; Zafar A; Nazish S; Alshamrani F; Ishaque N; Alabdali M; Albakr A; Jaafari DA; Alkhamis FA; Shariff E; Soltan NM; Saqqur M
    Prim Care Companion CNS Disord; 2021 Nov; 23(6):. PubMed ID: 34818472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.